Bacitracin FDA Link Generic

A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)

Also Known As:

Baci-Rx; Baciguent; Ak-Tracin; Altracin; Baci-IM; Bacitin; Bacitracin Zinc; Bacitracin Zinc Complex; Bacitracine Martinet; Ocu-Tracin; Topitracin; Zeba-Rx; Zinc Bacitracin; Ak Tracin; Baci IM; Baci Rx; Bacitracin, Zinc; Martinet, Bacitracine; Ocu Tracin; OcuTracin; Zeba Rx; Zinc, Bacitracin

Pharmalogical Action Categories:

Anti-Bacterial Agents
Anti-Infective Agents, Local

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Bacitracin: 483
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Bacitracin: 483

Luke Southey Selected Research

Luke Southey Research Topics

Disease

Drug/Important Bio-Agent (IBA)